Sort
40,608 grants matching “prostate cancer”
Towards Understanding Prostate Cancer Heterogeneity
$365,372Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · CA
Towards Understanding Prostate Cancer Heterogeneity
$365,314Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · CA
MicroRNAs in African American Prostate Cancer
$365,305Deepak Kumar · North Carolina Central University · U01 · FY2016 · CA
SYSTEMATIC ASSESS OF GENE EXPRESSION IN MOUSE PROSTATE
$365,269Wake Forest University Health Sciences · R01 · FY2001 · ES
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$365,255Kathleen Kelly · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer
$365,216Don X Nguyen · Yale University · R01 · FY2015 · CA
Chlorotoxin as a Targeting Agent for Cancer Therapies
$365,200James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Chlorotoxin as a Targeting Agent for Cancer Therapies
$365,200James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Regulation of glucose metabolism to allow tumor initiation and growth
$365,160Matthew G. Vander Heiden · Massachusetts Institute Of Technology · R01 · FY2019 · CA
TR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical care
$365,156Els Fieremans · New York University School Of Medicine · P41 · FY2019 · EB
CALGB
$365,117Ohio State University · U10 · FY2002 · CA
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
$365,103Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2019 · CA
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
$365,099Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2021 · CA
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
$365,099Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2020 · CA
Adhesion of Metastatic Tumor Cells in the Bloodstream
$365,089Michael R King · Cornell University · U54 · FY2012 · CA
Chemical Glycoproteomics
$365,056Carolyn R Bertozzi · Stanford University · R01 · FY2015 · CA
Lung Cancer Drivers and Dependencies as Therapeutic Targets
$365,049Scott W Lowe · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Subcellular Distribution & Regulation of ala-Adrenocepto
$365,049Debra A. Schwinn · University Of Washington · R37 · FY2007 · HL
Lung Cancer Drivers and Dependencies as Therapeutic Targets
$365,049Scott W Lowe · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)
$365,015Xuefeng Liu · Ohio State University · R01 · FY2020 · CA
Magnetic Resonance Elastography
$365,000Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · EB
HEI: ECLIPSE RD CYCLOTRON: CANCER: BRAIN, PROSTATE, BREAST, OVARIAN
$365,000Sloan-Kettering Institute For Cancer Res · S10 · FY2004 · RR
P13K/PTEN/Akt signaling and the genesis of cancer
$364,986Nissim Hay · University Of Illinois At Chicago · R01 · FY2007 · CA
Cancer stem cells and human liver cancer
$364,963Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
ANDROGEN INDEPENDENT PROSTATE CANCER:A TRANSGENIC MODEL
$364,963Baylor College Of Medicine · R01 · FY2002 · CA